KREMERS URBAN DEVELOPMENT COMPANY v. ESTEVE QUIMICA, S.A.
1:03-cv-01684
Overview
Parties
Defendant
MYLAN PHARMACEUTICALS, INC. Operating Company
Represented By
1 Attorneys ListedLEVY & GRANDINETTI
LEVY & GRANDINETTI, 1120 Connecticut Ave, NW
ESTEVE QUIMICA, S.A. NPE (Individual / Inventor)
Represented By
1 Attorneys ListedLEVY & GRANDINETTI
LEVY & GRANDINETTI, 1120 Connecticut Ave, NW
Plaintiff
PAWAN SETH NPE (Individual / Inventor)
Represented By
3 Attorneys ListedLEXICON GENETICS INCORPORATED
LEXICON GENETICS INCORPORATED, 8800 Technology Forest Place
U.S. INTERNATIONAL TRADE COMMISSION
U.S. INTERNATIONAL TRADE COMMISSION, 500 E Street, SW
RATNERPRESTIA, P.C.
1090 Vermont Avenue, NW, Suite 1200
KREMERS URBAN DEVELOPMENT COMPANY Operating Company
Represented By
3 Attorneys ListedLEXICON GENETICS INCORPORATED
LEXICON GENETICS INCORPORATED, 8800 Technology Forest Place
U.S. INTERNATIONAL TRADE COMMISSION
U.S. INTERNATIONAL TRADE COMMISSION, 500 E Street, SW
RATNERPRESTIA, P.C.
1090 Vermont Avenue, NW, Suite 1200
Court & Judges
Court
District Court, District of Columbia (dcd)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360Β° Radar 9 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| πΊπΈ United States | Asserted | Asserted Patent | View Official Patent → |
| π«π· France | France Counterpart | View Official Patent → | |
| π«π· France | France Counterpart | View Official Patent → | |
| π«π· France | France Counterpart | View Official Patent → | |
| π«π· France | France Counterpart | View Official Patent → | |
| π«π· France | France Counterpart | View Official Patent → | |
| π«π· France | France Counterpart | View Official Patent → | |
| π«π· France | France Counterpart | View Official Patent → | |
| π PCT International (WIPO) | PCT World Application | View Official Patent → |
No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.
Patents Involved
There are 3 patents involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US6159499
Composition containing an acid-labile benzimidazole and process for its preparation
|
Filed: 1996-09-23
Issued: 2000-12-12
|
Expired (Term Ended)
Expires: 2016-09-23
|
|
|
US6207198
Composition containing an acid-labile omeprazole and process for its preparation
|
Filed: 1996-09-23
Issued: 2001-03-27
|
Expired (Term Ended)
Expires: 2016-09-23
|
|
|
US6248355
Pharmaceutical composition containing an acid-labile omeprazole and process for its preparation
|
Filed: 1999-12-30
Issued: 2001-06-19
|
Expired (Term Ended)
Expires: 2019-12-30
|
Patent Enforceability & Injunction Risk Assessment
Statutorily Barred β Patent expired. Under 35 U.S.C. Β§ 283, injunctive relief is barred.
Standard Statutory Term β No obviousness-type double patenting noted.
Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).
Procedural Motions & Interlocutory Orders
Total Motions
13
Dispositive
5
Granted
10
Denied
0
Pending / Review
2
Motions by Category
Key Dispositive Motions & Rulings